Carles Blanch

422 total citations
28 papers, 294 citations indexed

About

Carles Blanch is a scholar working on Economics and Econometrics, Immunology and Infectious Diseases. According to data from OpenAlex, Carles Blanch has authored 28 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 9 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Carles Blanch's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and HIV/AIDS Research and Interventions (6 papers). Carles Blanch is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Psoriasis: Treatment and Pathogenesis (8 papers) and HIV/AIDS Research and Interventions (6 papers). Carles Blanch collaborates with scholars based in Spain, Switzerland and Italy. Carles Blanch's co-authors include Marta Comellas, Luís Lizán, R. Rivera, I. Belinchón, M. Figueras, José M. Martínez-Sánchez, Esteve Fernández, Carlo La Vecchia, Silvano Gallus and Marcela Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Social Science & Medicine.

In The Last Decade

Carles Blanch

27 papers receiving 286 citations

Peers

Carles Blanch

IMMUN

DERMA

PHYSI

GHP

Seina Lee United States

M.T. Caloto Spain

Rachael Thorneloe United Kingdom

Luís Araújo Portugal

Filiz Topaloğlu Demir Türkiye

Eugena Stamuli United Kingdom

Sherif Abaza Hungary

Malcolm Hogan United States

Sabina Ali United States

Petra Díaz del Campo Spain

Seina Lee United States

Carles Blanch

145 ×1.1

IMMUN

85 ×1.3

DERMA

23 ×0.4

PHYSI

49 ×0.9

13 ×0.3

GHP

Citations per year, relative to Carles Blanch Carles Blanch (= 1×) peers Seina Lee

Countries citing papers authored by Carles Blanch

Since Specialization

Citations

This map shows the geographic impact of Carles Blanch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Blanch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Blanch more than expected).

Fields of papers citing papers by Carles Blanch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carles Blanch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Blanch. The network helps show where Carles Blanch may publish in the future.

Co-authorship network of co-authors of Carles Blanch

This figure shows the co-authorship network connecting the top 25 collaborators of Carles Blanch. A scholar is included among the top collaborators of Carles Blanch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carles Blanch. Carles Blanch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López, Francisco Cabrera, et al.. (2022). Cost minimization analysis of brolucizumab in the treatment of neovascular age-related macular degeneration. Archivos de la Sociedad Española de Oftalmología (English Edition). 98(3). 155–162. 1 indexed citations

López, Francisco Cabrera, et al.. (2022). Análisis de minimización de costes de brolucizumab en el tratamiento de la degeneración macular asociada a la edad neovascular. Archivos de la Sociedad Española de Oftalmología. 98(3). 155–162. 1 indexed citations

López, Pedro Ruiz, et al.. (2022). Consideraciones prácticas para la implementación de proyectos de medición de resultados en salud en una organización sanitaria: Estudio Delphi de consenso de expertos. Journal of Healthcare Quality Research. 37(5). 326–334. 1 indexed citations

Gallego‐Pinazo, Roberto, et al.. (2021). Patient and retina specialists’ preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment. PLoS ONE. 16(12). e0261955–e0261955. 4 indexed citations

Cáliz, Rafael, et al.. (2021). A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis. Reumatología Clínica (English Edition). 17(9). 536–542. 2 indexed citations

Carretero, G., et al.. (2020). Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study. SHILAP Revista de lepidopterología. 7(1). 50–56. 8 indexed citations

Puig, L., et al.. (2020). Carga de la psoriasis en Cataluña: datos epidemiológicos, comorbilidades asociadas, uso de recursos sanitarios e incapacidad laboral. Actas Dermo-Sifiliográficas. 112(5). 425–433. 7 indexed citations

Merino, María, et al.. (2020). The Social Return on Investment of a New Approach to Heart Failure in the Spanish National Health System. ESC Heart Failure. 7(1). 131–138. 12 indexed citations

Torre‐Alonso, Juan Carlos, Rubén Queiró, Marta Comellas, Luís Lizán, & Carles Blanch. (2018). Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. Patient Preference and Adherence. Volume 12. 733–747. 18 indexed citations

10.

Blanch, Carles, et al.. (2016). Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Quality of Life Research. 25(11). 2739–2754. 47 indexed citations

11.

Blanch, Carles, Marta Comellas, César de Prada, & Luís Lizán. (2016). Economic Burden of Ankylosing Spondylitis In Europe. A Systematic Review of The Literature. Value in Health. 19(7). A541–A542. 2 indexed citations

12.

Gonzalez, Adriano Miziara, et al.. (2016). Social Return on Investment in Psoriasis. Value in Health. 19(7). A612–A612. 1 indexed citations

13.

Belinchón, I., R. Rivera, Carles Blanch, Marta Comellas, & Luís Lizán. (2016). Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Preference and Adherence. Volume 10. 2357–2367. 75 indexed citations

14.

Blanch, Carles, et al.. (2015). Biologic treatments for moderate-severe psoriasis. What efficacy gives you, cost should not take it away. Value in Health. 18(7). A417–A417. 1 indexed citations

15.

Fernández, Esteve, et al.. (2013). Tobacco smoking, exposure to second‐hand smoke, and asthma and wheezing in schoolchildren: a cross‐sectional study. Acta Paediatrica. 102(7). e305–9. 21 indexed citations

16.

Martínez-Sánchez, José M., Carles Blanch, Marcela Fu, et al.. (2013). Do smoke-free policies in work and public places increase smoking in private venues?: Table 1. Tobacco Control. 23(3). 204–207. 29 indexed citations

17.

Blanch, Carles, Esteve Fernández, José M. Martínez-Sánchez, et al.. (2013). Impact of a multi-level intervention to prevent secondhand smoke exposure in schoolchildren: A randomized cluster community trial. Preventive Medicine. 57(5). 585–590. 10 indexed citations

18.

Casado, María Jesús, et al.. (2004). [Survey of the performance of anti-HIV antibody detection tests in laboratories in Catalonia [Spain]].. PubMed. 18(1). 68–71. 2 indexed citations

19.

Casabona, Jordi, et al.. (2001). Evolución de la epidemia de la infección por el VIH en el siglo XXI. Medicina integral: Medicina preventiva y asistencial en atención primaria de la salud. 37(10). 419–427. 2 indexed citations

20.

Wang, Jen, et al.. (1997). HIV testing history among gay/bisexual men recruited in Barcelona: Evidence of high levels of risk behavior among self-reported HIV+ men. Social Science & Medicine. 44(4). 469–477. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact